Anis Emilia, Grotto Itamar, Moerman Larisa, Warshavsky Bruce, Slater Paul E, Lev Boaz, Israeli Avi
Ministry of Health, Jerusalem 93591, Israel.
J Infect. 2009 Oct;59(4):252-8. doi: 10.1016/j.jinf.2009.07.005. Epub 2009 Jul 17.
Despite success in controlling measles through a national immunization program, Israel recently experienced its largest measles outbreak since 1994.
Using data reported by health district offices to the Ministry of Health, an epidemiological analysis of the 2007-08 measles outbreak was performed.
1467 measles cases were reported in Israel, primarily among ultra-orthodox Jewish communities in the Jerusalem Health District and to a lesser extent in other areas. The highest age-specific incidence rate (122.5 per 100,000) occurred among infants. 38.6% of all measles patients were under the age of five, and 53.4% were under the age of ten. 186 patients (12.7%) were hospitalized; there were no fatalities. Only 4.6% of measles patients had been fully vaccinated for their age.
To minimize the risk of future outbreaks in Israel, successful marketing of the MMR vaccine to under-vaccinated sub-groups is essential.
尽管通过国家免疫计划成功控制了麻疹,但以色列最近经历了自1994年以来最大规模的麻疹疫情。
利用各卫生区办公室向卫生部报告的数据,对2007 - 2008年麻疹疫情进行了流行病学分析。
以色列报告了1467例麻疹病例,主要集中在耶路撒冷卫生区的极端正统犹太社区,其他地区的病例较少。婴儿的年龄别发病率最高(每10万人中122.5例)。所有麻疹患者中38.6%年龄在五岁以下,53.4%年龄在十岁以下。186名患者(12.7%)住院治疗;无死亡病例。仅4.6%的麻疹患者按年龄完成了全程疫苗接种。
为将以色列未来疫情爆发的风险降至最低,向疫苗接种不足的亚群体成功推广麻疹、腮腺炎和风疹(MMR)疫苗至关重要。